Biochemical recurrence following radical prostatectomy: A comparison between prostate cancers located in different anatomical zones

Prostate

Volumn 55, Issue 1, 2003, Pages 48-54

  Augustin, Herbert ^a,b   Erbersdobler, Andreas ^a   Graefen, Markus ^a   Fernandez, Salvador ^a   Palisaar, Jüri ^a   Huland, Hartwig ^a   Hammerer, Peter ^a,c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Prostate specific antigen; Prostatectomy; Prostatic neoplasms; Zonal anatomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CONVALESCENCE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; RECURRENT DISEASE; STATISTICAL ANALYSIS; TUMOR VOLUME;

ADULT; AGED; DISEASE-FREE SURVIVAL; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0037382928     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10216     Document Type: Article

References (18)

1. McNeal JE. Regional morphology and pathology of the prostate. Am J Clin Pathol 1968;49:347-357.
2. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma: Correlation with histologic pattern and direction of spread. Am J Surg Path 1988;12:897-906.
3. Stamey TA, Yemoto CM, McNeal JE, Sigal BM, Johnstone IM. Prostate cancer is highly predictable: A prognostic equation based on all morphological variables in radical prostatectomy specimens. J Urol 2000;163:1155-1160.
4. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001;58:843-848.
5. Reissigl A, Pointner J, Strasser H, Ennemoser O, Klocker H, Bartsch G. Frequency and clinical significance of transition zone cancer in prostate cancer screening. Prostate 1997;30:130-135.
6. Stamey TA, Sozen TS, Yemoto CM, McNeal JE. Classification of localized untreated prostate cancer based on 791 men treated only with radical prostatectomy: Common ground for therapeutic trials and TNM subgroups. J Urol 1998;159:2009-2012.
7. Noguchi M, Stamey TA, Neal JE, Yemoto CE. An analysis of 148 consecutive transition zone cancers: Clinical and histological characteristics. J Urol 2000;163:1751-1755.
8. Sobin LH, Wittekind C. UICC TNM classification of malignant tumors, 5th edition. New York: Wiley-Liss; 1997.
9. Henke RP, Krueger E, Ayhan N, Huebner D, Hammerer H, Huland H. Immunohistochemical detection of p53 protein in human prostatic cancer. J Urol 1994;152:1297-1301.
10. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999;17:1499-1507.
11. D'Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Tomaszewski JE, Wein A. The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer. J Urol 1998;160:2096-2101.
12. Epstein JI, Partin AW, Sauvageot J, Walsh PC. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 1996;20:286-292.
13. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002;167:528-534.
14. Greene DR, Wheeler TM, Egawa S, Dunn JK, Scardino PT. A comparison of the morphological features of cancers arising in the transition zone and in the peripheral zone of the prostate. J Urol 1991;146:1069-1076.
15. Erbersdobler A, Fritz H, Schnoeger S, Graefen M, Hammerer P, Huland H, Henke RP. Tumour grade, proliferation, apotosis, microvessel density, p53 and bcl-2 in prostate cancers: differences between tumours located in the transition zone and the peripheral zone. Eur Urol 2002;41:40-46.
16. Grignon DJ, Sakr WA. Zonal origin of prostatic adenocarcinoma: Are there biologic differences between transition zone and peripheral zone adenocarcinomas of the prostate gland? J Cell Biochem 1994;19:267-269.
17. Erbersdobler A, Hammerer P, Huland H, Henke RP. Numerical chromosomal aberrations in transition zone carcinomas of the prostate. J Urol 1997;158:1594-1598.
18. McNeal JE. Cancer volume and site of origin of adenocarcinoma of the prostate: Relationship to local and distant spread. Hum Path 1992;23:258-266.